Company Filing History:
Years Active: 2007
Title: Lluís Solà Carandell: Innovator in Antiepileptic Agents
Introduction
Lluís Solà Carandell is a notable inventor based in La Garriga, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiepileptic agents. His innovative work has led to the creation of a process that enhances the production of a vital pharmaceutical ingredient.
Latest Patents
Lluís Solà Carandell holds a patent for a process for obtaining the pharmaceutical active ingredient, levetiracetam. This process involves the deaminomethylation of a sufficiently pure enantiomer intermediate, or an addition salt thereof with an acid. The invention is designed to facilitate the industrial-scale production of levetiracetam without the need for hydrogenation or chromatography.
Career Highlights
Lluís Solà Carandell is associated with Esteve Química S.A., a company known for its commitment to pharmaceutical innovation. His work has been instrumental in advancing the methods used to produce essential medications for epilepsy treatment.
Collaborations
Throughout his career, Lluís has collaborated with esteemed colleagues such as Juan José Artús Surroca and Llorenç Rafecas Jané. These partnerships have contributed to the successful development and implementation of his innovative processes.
Conclusion
Lluís Solà Carandell's contributions to the pharmaceutical industry, particularly in the production of antiepileptic agents, highlight his role as a significant inventor. His patented process for levetiracetam showcases his commitment to advancing medical science and improving patient care.